(Q72617595)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Monitoring of antiviral therapy with quantitative evaluation of HBeAg: a comparison with HBV DNA testing (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

R Perrillo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

L Mimms

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

K Schechtman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

D Robbins

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

C Campbell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

English

0 references

publication date

1 December 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

1306-1312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

Interferon in the management of chronic hepatitis B.

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180604

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180604

7 January 2021

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180604

7 January 2021

Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180604

7 January 2021

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180604

7 January 2021

Serological detection of HBeAg and anti-HBe using automated microparticle enzyme immunoassays

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180604

7 January 2021

Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180604

7 January 2021

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180604

7 January 2021

Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180604

7 January 2021

Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180604

7 January 2021

Identifiers

DOI

10.1002/HEP.1840180604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8244253%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference